Update on Pediatric Hepatitis C Infection

Overview

Journal Curr Gastroenterol Rep

Specialty Gastroenterology

Date 2025 Feb 28

PMID 40019674

Authors

Johanna Ferreira

Shari Sheflin-Findling

Affiliations

Soon will be listed here.

Abstract

Purposeof Review: Hepatitis C virus (HCV) infections continue to steadily increase in the United States and remain a major public health challenge. This review aims to provide a comprehensive overview of HCV infection in children, focusing on recent advancements in screening, diagnosis, and treatment.

Recent Findings: Effective screening strategies, including universal screening of pregnant women and nucleic acid testing for all perinatally exposed infants at 2 to 6 months of age, have been implemented to identify infected individuals early. Direct-acting antiviral agents have revolutionized treatment, offering high cure rates for children of all ages. Despite significant progress, challenges remain in achieving HCV elimination. These include the need for improved access to testing and treatment, as well as ongoing efforts to develop a preventive vaccine. Continued research and implementation of effective strategies are essential to reduce the burden of HCV infection.

References

Greenaway E, Haines A, Ling S, Krahn M . Treatment of Chronic Hepatitis C in Young Children Reduces Adverse Outcomes and Is Cost-Effective Compared with Deferring Treatment to Adulthood. J Pediatr. 2020; 230:38-45.e2. DOI: 10.1016/j.jpeds.2020.08.088. View

Murray K, Balistreri W, Bansal S, Whitworth S, Evans H, Gonzalez-Peralta R . Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11. Hepatology. 2018; 68(6):2158-2166. DOI: 10.1002/hep.30123. View

Casiraghi M, De Paschale M, Romano L, Biffi R, Assi A, Binelli G . Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology. 2004; 39(1):90-6. DOI: 10.1002/hep.20030. View

Squires Jr R, Shneider B, Bucuvalas J, Alonso E, Sokol R, Narkewicz M . Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006; 148(5):652-658. PMC: 2662127. DOI: 10.1016/j.jpeds.2005.12.051. View

Klevens R, Hu D, Jiles R, Holmberg S . Evolving epidemiology of hepatitis C virus in the United States. Clin Infect Dis. 2012; 55 Suppl 1:S3-9. PMC: 5774980. DOI: 10.1093/cid/cis393. View

Owens D, Davidson K, Krist A, Barry M, Cabana M, Caughey A . Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020; 323(10):970-975. DOI: 10.1001/jama.2020.1123. View

. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis. 2005; 41(1):45-51. DOI: 10.1086/430601. View

Ryerson A, Schillie S, Barker L, Kupronis B, Wester C . Vital Signs: Newly Reported Acute and Chronic Hepatitis C Cases - United States, 2009-2018. MMWR Morb Mortal Wkly Rep. 2020; 69(14):399-404. PMC: 7147907. DOI: 10.15585/mmwr.mm6914a2. View

Thomas D, Astemborski J, RAI R, Anania F, Schaeffer M, Galai N . The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000; 284(4):450-6. DOI: 10.1001/jama.284.4.450. View

10.

Iorio R, Giannattasio A, Sepe A, Terracciano L, Vecchione R, Vegnente A . Chronic hepatitis C in childhood: an 18-year experience. Clin Infect Dis. 2005; 41(10):1431-7. DOI: 10.1086/497141. View

11.

Mast E, Hwang L, Seto D, Nolte F, Nainan O, Wurtzel H . Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis. 2005; 192(11):1880-9. DOI: 10.1086/497701. View

12.

Bhattacharya D, Aronsohn A, Price J, Re V . Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis. 2023; . DOI: 10.1093/cid/ciad319. View

13.

Leung D, Squires J, Jhaveri R, Kerkar N, Lin C, Mohan P . Hepatitis C in 2020: A North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper. J Pediatr Gastroenterol Nutr. 2020; 71(3):407-417. DOI: 10.1097/MPG.0000000000002814. View

14.

Messina J, Humphreys I, Flaxman A, Brown A, Cooke G, Pybus O . Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2014; 61(1):77-87. PMC: 4303918. DOI: 10.1002/hep.27259. View

15.

Murphy D, Sablon E, Chamberland J, Fournier E, Dandavino R, Tremblay C . Hepatitis C virus genotype 7, a new genotype originating from central Africa. J Clin Microbiol. 2014; 53(3):967-72. PMC: 4390628. DOI: 10.1128/JCM.02831-14. View

16.

Gregory E, Ely D . Trends and Characteristics in Prepregnancy Diabetes: United States, 2016-2021. Natl Vital Stat Rep. 2023; 72(6):1-13. View

17.

Goodman Z, Makhlouf H, Liu L, Balistreri W, Gonzalez-Peralta R, Haber B . Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial. Hepatology. 2008; 47(3):836-43. PMC: 3755275. DOI: 10.1002/hep.22094. View

18.

Nguyen J, Barritt 4th A, Jhaveri R . Cost Effectiveness of Early Treatment with Direct-Acting Antiviral Therapy in Adolescent Patients with Hepatitis C Virus Infection. J Pediatr. 2019; 207:90-96. DOI: 10.1016/j.jpeds.2018.12.012. View

19.

Jonas M, Romero R, Rosenthal P, Lin C, Verucchi G, Wen J . Sofosbuvir-velpatasvir in children 3-17 years old with hepatitis C virus infection. J Pediatr Gastroenterol Nutr. 2024; 78(6):1342-1354. DOI: 10.1002/jpn3.12045. View

20.

Jara P, Resti M, Hierro L, Giacchino R, Barbera C, Zancan L . Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis. 2003; 36(3):275-80. DOI: 10.1086/345908. View